Prognostic significance of systemic immune‐inflammation index in patients with nonfunction pancreatic neuroendocrine tumor undergoing surgical resection

Documenti analoghi

• Prognostic significance of glucose‐lipid metabolic index in pancreatic cancer patients with diabetes mellitus
  di: Hailiang Wang, et al.
  Pubblicazione: (2024)
• Prognostic impact of bridge or neoadjuvant induction chemotherapy in patients with resected oral cavity cancer: A nationwide cohort study
  di: Cheng‐Lung Hsu, et al.
  Pubblicazione: (2024)
• Surufatinib combined with transarterial embolization versus surufatinib monotherapy in patients with liver metastatic neuroendocrine tumors: Study protocol for a prospective, randomized, controlled trial
  di: Ruizhen Li, et al.
  Pubblicazione: (2024)
• Clinicopathological characteristics of gastric neuroendocrine neoplasms: A comprehensive analysis
  di: Mengli Zi, et al.
  Pubblicazione: (2024)
• Prognostic analysis and outcomes of metastatic pancreatic cancer patients receiving nab ‐paclitaxel plus gemcitabine as second or later‐line treatment
  di: Guido Giordano, et al.
  Pubblicazione: (2024)